BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9042307)

  • 1. Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts.
    Lapis KY; Bocsi J; Tóvári J; Bartha I; Timár J; Rásó E
    Anticancer Res; 1996; 16(6A):3323-31. PubMed ID: 9042307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
    Tóvári J; Bocsi J; Ladányi A; Lapis K; Timár J
    Anticancer Res; 1996; 16(6A):3307-12. PubMed ID: 9042305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSU-68 (SU6668) inhibits local tumor growth and liver metastasis of human colon cancer xenografts via anti-angiogenesis.
    Yorozuya K; Kubota T; Watanabe M; Hasegawa H; Ozawa S; Kitajima M; Chikahisa LM; Yamada Y
    Oncol Rep; 2005 Sep; 14(3):677-82. PubMed ID: 16077974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.
    Tímár J; Tóvári J; Pogány G; Ladányi A; Paku S; Rśó E; Bocsi J; Jeney A; Lapis K
    Eur J Cancer; 1996 Jan; 32A(1):152-9. PubMed ID: 8695225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the progression of human and rat Wilms' tumor by Tiazofurin.
    Rásó E; Tímár J; Lapis K
    Anticancer Res; 1996; 16(6A):3333-9. PubMed ID: 9042308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
    Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
    Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice.
    Sun LQ; Li YX; Guillou L; Mirimanoff RO; Coucke PA
    Cancer Res; 1997 Sep; 57(18):4023-8. PubMed ID: 9307288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line.
    Yoshida Y; Kishimoto T; Ishiguro H; Nagai Y; Koda K; Takiguchi N; Miyazaki M; Ishikura H
    Exp Mol Pathol; 2006 Aug; 81(1):77-84. PubMed ID: 16380115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
    Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
    Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver metastasis models of human colo-rectal carcinoma established in nude mice by orthotopic transplantation and their biologic characteristics].
    Liu Q; Tuo C; Wu B
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):98-100. PubMed ID: 10920954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
    Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
    Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
    Kitamura M; Arai K; Iwasaki Y; Takahashi T; Saitoh K; Fujii T; Shirasaka T
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):559-63. PubMed ID: 10790998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
    Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
    Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.